USAID’s Bureau for Global Health, Office of Infectious Disease, Neglected Tropical Diseases Division is pleased to announce the award of the Control and Elimination Program for Neglected Tropical Diseases (CEP-NTD) Element One. CEP-NTD builds on the successes that have been achieved through previous Agency investments to expand and strengthen national integrated NTD programs to achieve the WHO 2020 NTD goals. CEP-NTD will continue to support countries in their advancement toward global elimination goals, and support countries to effectively access and leverage drug donations needed to control the NTDs that cannot be eliminated with current strategies. This new five-year award is intended to support disease-endemic countries to control and/or eliminate NTDs with proven, cost-effective public health interventions to treat and measure treatment impact against seven NTDs: lymphatic filariasis, blinding trachoma, onchocerciasis, schistosomiasis, and three intestinal worms known as soil-transmitted helminths. The Agency will continue to ensure that these investments coordinate with current investments from other donors and the pharmaceutical sector and will look to involve new sectors..

This cooperative agreement has been awarded to FHI 360 with a $200 million ceiling. FHI 360 has arranged a consortium of partners to implement the objectives of CEP-NTD: Helen Keller International, Health Development International, Deloitte, World Vision, Americares and the AIM Initiative. This cooperative agreement will support Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone and Togo. The CEP-NTD Element Two award, which includes a different subset of focal countries, is still under solicitation.